Amid fears of fines for not wearing masks following the DDMA order, people in the national capital have again started wearing masks in public places, especially in busy markets, railway stations, metro, buses and ISBTs. Inspection at these places by Delhi Police and officials has also been intensified once again.
According to the health department, Delhi on Sunday reported 1,083 fresh COVID-19 infections with a positivity rate of 4.48 per cent, while one person died due to the disease. The number of infections in the national capital now stands at 18,74,876 and the death toll is 26,168. The capital had reported 1,094 COVID-19 infections on Saturday, the highest since February 10, with a positivity rate of 4.82 per cent and two deaths.
Meanwhile, Mumbai recorded 73 new coronavirus positive cases on Sunday, taking its total infection count to 10,59,286, according to PTI. The death toll in the city remained unchanged at 19,562 as none succumbed to the infection during the day. On Saturday, 72 cases were reported in the city.
A common anti-inflammatory drug has been found to be an effective antiviral agent in the treatment of mild and moderate COVID-19 patients. The drug, indomethacin, is widely used to treat a variety of inflammatory conditions. The study conducted by IIT Madras on Kovid patients has been published in Nature Scientific Reports.
Medication: Indomethacin is a non-steroidal anti-inflammatory drug available as capsules and a liquid suspension, to be taken orally. According to the US National Library of Medicine, indomethacin works by stopping the body’s production of substances that cause pain, fever, and inflammation. It is used to relieve moderate to severe pain, tenderness, swelling, and stiffness caused by various types of arthritis, and shoulder pain due to inflammation.
Conclusion: A randomized clinical trial was conducted by researchers from IIT Madras at Panimlar Medical College and Research Institute, Chennai. A media release from IIT Madras said that of the 210 patients recruited, 107 were randomly allocated to a control group and treated with paracetamol and standard care, while 103 patients were treated with standard care. Indomethacin was given with care.
Read also | New research: Common medicine found effective against mild and moderate covid
A UK patient with a severely weakened immune system had Covid-19 for almost a year and a half, scientists have reported, underscoring the importance of protecting vulnerable people from the coronavirus. There is no way to know for sure whether this was the longest lasting Covid-19 infection as not everyone is tested, especially regularly in this case.
But at 505 days, “it certainly seems to be the longest reported infection,” said Dr Luke Blagdon Snell, an infectious disease specialist at Guy and St Thomas’ NHS Foundation Trust.